Last updated on February 2018

DNS-3379 vs. Placebo in Stroke Rehabilitation

Brief description of study

This is a randomized, double-blind, placebo-controlled parallel group outpatient 42-day treatment study that will utilize standard stroke rehabilitation outcome measures to evaluate the effect of DNS-3379 on upper extremity motor recovery in subjects following ischemic stroke.

Clinical Study Identifier: NCT03254160

Contact Investigators or Research Sites near you

Start Over

Dart Neuroscience. LLC

Repatriation General Hospital
Daw Park, Australia
  Connect »True

Dart Neuroscience. LLC

Royal Adelaide Hospital
Adelaide, Australia
  Connect »True